Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,553,911
+$1,130,318 QoQ
Shares Held
2,963
+12.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#1,987
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sagewood Asset Management LP holds $14,933,530 across 11 Drug Manufacturers - General names. LLY ranks #1 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,963 | $3,553,911 | |
| 2 | JNJ |
Johnson & Johnson
|
10,651 | $2,705,034 | |
| 3 | ABBV |
AbbVie Inc.
|
7,717 | $1,941,905 | |
| 4 | BIIB |
Biogen Inc.
|
6,484 | $1,400,933 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
10,598 | $1,338,951 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,934 | $1,148,019 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
15,270 | $879,857 | |
| 8 | AMGN |
Amgen Inc
|
2,078 | $752,485 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,553,911 | 2,963 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,423,593 | 2,635 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,516,900 | 2,342 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||